We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Roche Diagnostics and Protedyne Sign Global Agreement

By Biotechdaily staff writers
Posted on 12 Feb 2007
Roche Diagnostics (Indianapolis, In, USA) and Protedyne (Windsor, CT, USA), a company offering industrial robotic solutions, are bringing together their latest technologies for the benefit of scientists worldwide. More...
In a collaborative effort, the two companies have integrated their technologies to provide a rapid and completely automated solution for high throughput quantitative polymerase chain reaction (PCR) applications.

Roche's LightCycler 480 instrument is a 96- or 384-well, plate-based quantitative PCR instrument. Combining speed with accuracy, the LightCycler 480 is a novel platform for gene-expression and mutation analysis. Based on innovative hardware and software, the LightCycler 480 instrument meets the needs of a broad range of genomic applications. The instrument builds upon the sensitivity and accuracy of the well-established LightCycler System, and now enables rapid high throughput quantitative PCR.

Protedyne's Radius is a new benchtop robotic system using the principles of industrial automation to offer high levels of flexibility, reproducibility, and process control for today's laboratories. Its radial design and vertical construction provide maximum functionality that can access areas of the bench top beyond its own footprint for simple and cost-effective device integration. The Radius system uses Protedyne's software that easily adapts to multiple protocols--and SmartTools, easily interchangeable tools with built-in microprocessors that store tool calibration information and track performance data.

Protedyne's Radius was a logical choice for the LightCycler 480 System as our technology provides the efficiency and throughput needed for highly- reproducible preparation across a broad range of scientific applications in genomics research, said Fran Tuttle, president and CEO of Protedyne. By combining the two systems, we can deliver to our customers exactly the throughput they are trying to achieve.



Related Links:
Roche Diagnostics
Protedyne

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Aspiration System
VACUSAFE
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.